It was shown that blocking IL-4/IL-13 signaling, in addition to suppressing systemic Th2-type inflammation, increased microbial diversity, reducing the abundance of S. aureus, with the recovery of the altered transcriptome of epidermal proteins associated with AD. Here, IL13 is linked to Alzheimer disease.